Biology Reference
In-Depth Information
Zhao Y, Zhang HT, O'Donnell JM (2003) Inhibitor binding to type 4 phosphodiesterase (PDE4)
assessed using [3H]piclamilast and [3H]rolipram. J Pharmacol Exp Ther 305:565-572
Zhu B, Strada SJ (2007) The novel functions of cGMP-specific phosphodiesterase 5 and its
inhibitors in carcinoma cells and pulmonary/cardiovascular vessels. Curr Top Med Chem 7:
437-454
Zoraghi R, Corbin JD, Francis SH (2004) Properties and functions of GAF domains in cyclic
nucleotide phosphodiesterases and other proteins. Mol Pharmacol 65:267-278
Zoraghi R, Bessay EP, Corbin JD, Francis SH (2005) Structural and functional features in human
PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and
regulation. J Biol Chem 280:12051-12063
Zoraghi R, Francis SH, Corbin JD (2007) Critical amino acids in phosphodiesterase-5 catalytic site
that provide for high-affinity interaction with cGMP and inhibitors. Biochemistry 46:
13554-13563
